rhodamine 123 has been researched along with Kahler Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CY; Huang, FI; Huang, HL; Lai, MJ; Lee, HY; Li, YH; Liou, JP; Nepali, K; Yang, CR | 1 |
| Anderson, K; Clynes, M; Delmore, J; Jakubikova, J; Klippel, S; Meiller, J; Mitsiades, CS; O'Connor, R; O'Gorman, P; Ooi, MG; Richardson, P | 1 |
| Jiang, YF; Wang, JH; Xu, P | 1 |
| den Ouden, D; Schoester, M; Sonneveld, P; van den Heuvel, M; van Rens, G | 1 |
| Belch, AR; Pilarski, LM; Szczepek, AJ | 1 |
| Belch, AR; Murphy, GF; Pilarski, LM; Yatscoff, RW | 1 |
| Almeida, J; Gutierrez, N; Martínez, A; Orfao, A; Pérez-Simón, JA; San Miguel, JF; Tabernero, D; Valverde, B | 1 |
7 other study(ies) available for rhodamine 123 and Kahler Disease
| Article | Year |
|---|---|
(N-Hydroxycarbonylbenylamino)quinolines as Selective Histone Deacetylase 6 Inhibitors Suppress Growth of Multiple Myeloma in Vitro and in Vivo.
Topics: Animals; Antineoplastic Agents; Caco-2 Cells; Cell Proliferation; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Multiple Myeloma; Quinolines; Rats | 2018 |
The interaction of bortezomib with multidrug transporters: implications for therapeutic applications in advanced multiple myeloma and other neoplasias.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Boronic Acids; Bortezomib; Cell Line; Cell Line, Tumor; Cellular Microenvironment; Coculture Techniques; Drug Resistance, Neoplasm; Fluorescent Dyes; Gene Expression Regulation; Humans; Multiple Myeloma; Pyrazines; Rhodamine 123; Stromal Cells | 2013 |
shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; ATP Binding Cassette Transporter, Subfamily B; Breast Neoplasms; Calcium-Binding Proteins; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Proliferation; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glioma; Hep G2 Cells; Humans; Multidrug Resistance-Associated Proteins; Multiple Myeloma; Rhodamine 123; RNA Interference; RNA, Small Interfering; Signal Transduction; Transfection | 2015 |
In vitro effect of GF120918, a novel reversal agent of multidrug resistance, on acute leukemia and multiple myeloma cells.
Topics: Acridines; Acute Disease; Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance, Multiple; Humans; Isoquinolines; Kinetics; Leukemia, Myeloid; Multiple Myeloma; Neoplasm Proteins; Polymerase Chain Reaction; Rhodamine 123; Rhodamines; Tetrahydroisoquinolines; Transcription, Genetic; Tumor Cells, Cultured | 1996 |
Deficient drug transporter function of bone marrow-localized and leukemic plasma cells in multiple myeloma.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Biological Transport; Bone Marrow Cells; Fluorescent Dyes; Humans; Molecular Sequence Data; Multiple Myeloma; Plasma Cells; Rhodamine 123; Rhodamines | 1997 |
Drug resistance in multiple myeloma: cyclosporin A analogues and their metabolites as potential chemosensitizers.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; B-Lymphocytes; Biological Transport; Cyclosporine; Cyclosporins; Drug Resistance, Neoplasm; Humans; Immunosuppressive Agents; Multiple Myeloma; Rhodamine 123; Rhodamines; Tumor Cells, Cultured | 1998 |
Correlation of rhodamine 123 efflux by neoplastic plasma cells with clinical and biological characteristics of multiple myeloma.
Topics: Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Aberrations; Chromosome Disorders; Female; Flow Cytometry; Humans; In Situ Hybridization, Fluorescence; Male; Middle Aged; Multiple Myeloma; Plasma Cells; Rhodamine 123 | 1999 |